fda warning letter hims compounded semaglutide september 2025 Why the Issued 30 Letters to Telehealth Sites Marketing GLP-1s U.S. FDA sends drug advertising

While certain GLP-1 medications are approved for diabetes and weight loss by the US Food and Drug Administration (FDA), most off-label semaglutide medications are compounded GLP-1s, which are not FDA-approved

In-Clinic & Mobile IV Care Visit our Las Vegas clinic or schedule a licensed mobile nurse to bring professional IV therapy directly to your hotel, home, or event

This differs from the approved low-dose titration schedules (such as starting semaglutide at 0.25mg) that manufacturers recommend to improve tolerability

Particularly public spaces have a distinctive role within planning

A dosing journal or tracking app